Works matching AU Kanellias, Nikolaos

Results: 68
    1

    Thrombotic and bleeding complications in patients with AL amyloidosis.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 5, p. 1816, doi. 10.1111/bjh.19331
    By:
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Sotiria;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Malandrakis, Panagiotis;
    • Dialoupi, Ioanna;
    • Roussou, Maria;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    2

    Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab‐based therapy.

    Published in:
    British Journal of Haematology, 2023, v. 203, n. 3, p. 411, doi. 10.1111/bjh.19042
    By:
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Spiliopoulou, Vasiliki;
    • Roussou, Maria;
    • Malandrakis, Panagiotis;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Migkou, Magdalini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Papanikolaou, Asimina;
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    3

    Myeloma patients with COVID‐19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 2, p. 356, doi. 10.1111/bjh.17841
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Malandrakis, Panagiotis;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Fotiou, Despina;
    • Papanagnou, Eleni‐Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis P.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios‐Athanasios
    Publication type:
    Article
    4

    Daratumumab‐based therapy for patients with monoclonal gammopathy of renal significance.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 1, p. 113, doi. 10.1111/bjh.17052
    By:
    • Kastritis, Efstathios;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Psimenou, Erasmia;
    • Gakiopoulou, Charikleia;
    • Marinaki, Smaragdi;
    • Gatou, Anastasia;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Malandrakis, Panagiotis;
    • Dialoupi, Ioanna;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Kostopoulos, Ioannis V.;
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    5

    Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy: A Single Center Database Review in Greece.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 7, p. 468, doi. 10.1016/j.clml.2024.03.003
    By:
    • Kastritis, Efstathios;
    • Ntanasis-Stathopoulos, Ioannis;
    • Theodorakakou, Foteini;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Malandrakis, Panagiotis;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Fotiou, Despina;
    • Spiliopoulou, Vassiliki;
    • Gavriatopoulou, Maria;
    • Patel, Sachin;
    • Majer, Istvan;
    • Boukis, Christos;
    • Fetani, Andriani;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    6

    P-209: High response rates with IMiD retreatment post anti-CD38 exposure in patients with Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S154, doi. 10.1016/S2152-2650(21)02336-3
    By:
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    7

    P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S104, doi. 10.1016/S2152-2650(21)02254-0
    By:
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Papanagnou, Eleni-Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    8

    Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma.

    Published in:
    2020
    By:
    • Kastritis, Efstathios;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Gika, Dimitra;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios C.;
    • Ntanasis-Stathopoulos, Ioannis;
    • Mparmparousi, Despoina;
    • Gatou, Anastasia;
    • Katopi, Despina;
    • Manios, Efstathios;
    • Liontos, Michail;
    • Giannouli, Stavroula;
    • Tsirigotis, Panagiotis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    journal article
    9

    Screening for Gaucher disease in patients with plasma cell dyscrasias.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e327, doi. 10.1016/j.clml.2019.09.537
    By:
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    10

    Primary Treatment of Light Chain (AL) Amyloidosis With Bortezomib, Lenalidomide and Dexamethasone (VRD) or with Bortezomib, Cyclophosphamide and Dexamethasone (VCD/CyBorD): efficacy and toxicity.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e320, doi. 10.1016/j.clml.2019.07.322
    By:
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Tselegkidi, Maria Irini;
    • Marinaki, Smaragdi;
    • Psimenou, Erasmia;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gakiopoulou, Harikleia;
    • Papanota, Aristea-Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    11

    Longitudinal Evaluation of Minimal Residual Disease in Patients with Multiple Myeloma who Achieve Complete Response After First Line Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e185, doi. 10.1016/j.clml.2019.09.310
    By:
    • Kostopoulos, Ioannis V.;
    • Kastritis, Efstathios;
    • Papanota, Aristea-Maria;
    • Micheli, Paraskevi;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    12

    Absence of Aberrant Plasma Cells in the Apheresis Product Predicts for Minimal Residual Disease Negativity after Autologous Transplantation in Myeloma Patients Who Receive First Line Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e184, doi. 10.1016/j.clml.2019.09.309
    By:
    • Terpos, Evangelos;
    • Kostopoulos, Ioannis V.;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanota, Aristea-Maria;
    • Micheli, Paraskevi;
    • Malandrakis, Panagiotis;
    • Kanellias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Liacos, Christine-Ivy;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    13

    Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S331, doi. 10.1016/j.clml.2019.07.322
    By:
    • Kastritis, Efstathios;
    • Dialoupi, Ioanna;
    • Gavriatopoulou, Maria;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Ntanasis-Stathopoulos, Ioannis;
    • Papadopoulou, Elektra;
    • Ziogas, Dimitrios C.;
    • Stamatelopoulos, Kimon;
    • Manios, Efstathios;
    • Ntalianis, Argyrios;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanikolaou, Asimina;
    • Migkou, Magdalini;
    • Gakiopoulou, Charikleia;
    • Psimenou, Erasmia;
    • Tselegkidi, Marini;
    • Tsitsilonis, Ourania;
    • Trougakos, Ioannis
    Publication type:
    Article
    14

    Incidence of Skeletal-Related Events at Diagnosis and at the Time of First Relapse in 463 Patients with Multiple Myeloma Who Received First Line Treatment in a Single Center.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S333, doi. 10.1016/j.clml.2019.07.325
    By:
    • Terpos, Evangelos;
    • Kanellias, Nikolaos;
    • Moulopoulos, Lia A.;
    • Christoulas, Dimitrios;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Bagratuni, Tina;
    • Koutoulidis, Vasilios;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    15

    Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma who Are Treated with Bortezomib-Based Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S325, doi. 10.1016/j.clml.2019.07.310
    By:
    • Papanota, Aristea-Maria;
    • Kastritis, Efstathios;
    • Papassotiriou, Gerasimos-Petros;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Margeli, Alexandra;
    • Migkou, Magdalini;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Psimenou, Erasmia;
    • Papassotiriou, Ioannis;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    16

    Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM.

    Published in:
    2019
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Papasotiriou, Ioannis;
    • Fotiou, Despoina;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios;
    • Dialoupi, Ioanna;
    • Eleutherakis Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    journal article
    17
    18

    Outcomes of Consecutive Patients With Newly Diagnosed Myeloma Requiring Dialysis: Dialysis Independence is Associated with Rapid Myeloma Response and Predicts for Longer Survival.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e62, doi. 10.1016/j.clml.2017.03.114
    By:
    • Dimopoulos, Meletios Athanasios;
    • Pouli, Anastasia;
    • Roussou, Maria;
    • Gavriatopoulou, Maria;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Ziogas, Dimitrios C.;
    • Panagiotidis, Ioannis;
    • Psimenou, Erasmia;
    • Matsouka, Charis;
    • Mparmparousi, Despoina;
    • Giannouli, Stavroula;
    • Terpos, Evangelos;
    • Kastritis, Efstathios
    Publication type:
    Article
    19
    20

    Addition of Cyclophosphamide and Higher Doses of Dexamethasone Do Not Improve Outcomes of Patients With AL amyloidosis Treated With Bortezomib.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e65, doi. 10.1016/j.clml.2017.03.119
    By:
    • Gavriatopoulou, Maria;
    • Roussou, Maria;
    • Ziogas, Dimitrios C.;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Panagiotidis, Ioannis;
    • Kanellias, Nikolaos;
    • Psimenou, Erasmia;
    • Papadopoulou, Elektra;
    • Pamboucas, Constatntinos;
    • Gakiopoulou, Harikleia;
    • Tasidou, Anna;
    • Giannouli, Stavroula;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Article
    21

    Prior Lenalidomide Resistance and the Impact of IMiD-free Interval in Patients Treated with Pomalidomide and Dexamethasone.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e115, doi. 10.1016/j.clml.2017.03.210
    By:
    • Dimopoulos, Meletios Athanasios;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Panagiotidis, Ioannis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Ziogas, Dimitrios C.;
    • Fotiou, Despina;
    • Giannouli, Stavroula;
    • Tsirigotis, Panagiotis;
    • Mparmparousi, Despoina;
    • Matsouka, Charis;
    • Delimpasi, Sossana;
    • Terpos, Evangelos;
    • Kastritis, Efstathios
    Publication type:
    Article
    22

    Denosumab effects on serum levels of the bone morphogenetic proteins antagonist noggin in patients with transfusion-dependent thalassemia and osteoporosis.

    Published in:
    Hematology, 2019, v. 24, n. 1, p. 318, doi. 10.1080/16078454.2019.1570617
    By:
    • Voskaridou, Ersi;
    • Ntanasis-Stathopoulos, Ioannis;
    • Christoulas, Dimitrios;
    • Sonnleitner, Linda;
    • Papaefstathiou, Athanasios;
    • Dimopoulou, Maria;
    • Missbichler, Albert;
    • Kanellias, Nikolaos;
    • Repa, Konstantina;
    • Papatheodorou, Athanasios;
    • Peppa, Melpomeni;
    • Hawa, Gerhard;
    • Terpos, Evangelos
    Publication type:
    Article
    23

    Denosumab effects on serum levels of the bone morphogenetic proteins antagonist noggin in patients with transfusion-dependent thalassemia and osteoporosis.

    Published in:
    Hematology, 2019, v. 24, n. 1, p. 318, doi. 10.1080/16078454.2019.1570617
    By:
    • Voskaridou, Ersi;
    • Ntanasis-Stathopoulos, Ioannis;
    • Christoulas, Dimitrios;
    • Sonnleitner, Linda;
    • Papaefstathiou, Athanasios;
    • Dimopoulou, Maria;
    • Missbichler, Albert;
    • Kanellias, Nikolaos;
    • Repa, Konstantina;
    • Papatheodorou, Athanasios;
    • Peppa, Melpomeni;
    • Hawa, Gerhard;
    • Terpos, Evangelos
    Publication type:
    Article
    24

    Re-evaluation of Mayo 2004 and revised Mayo 2012 staging in patients with AL amyloidosis in the era of new therapies.

    Published in:
    2025
    By:
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Spiliopoulou, Vasiliki;
    • Migkou, Magdalini;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Solia, Eirini;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Courraud, Julie;
    • Nikolaou, Panagiota-Efstathia;
    • Giannouli, Stavroula;
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Letter to the Editor
    25

    Pulmonary function tests reveal unrecognised lung dysfunction and have independent prognostic significance in patients with systemic AL amyloidosis.

    Published in:
    Amyloid, 2023, v. 30, n. 2, p. 153, doi. 10.1080/13506129.2022.2136519
    By:
    • Trakada, Georgia;
    • Fotiou, Despina;
    • Kallianos, Anastasios;
    • Theodorakakou, Foteini;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Kanellias, Nikolaos;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Dialoupi, Ioanna;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    26

    Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease.

    Published in:
    Amyloid, 2021, v. 28, n. 4, p. 259, doi. 10.1080/13506129.2021.1971192
    By:
    • Kastritis, Efstathios;
    • Rousakis, Pantelis;
    • Kostopoulos, Ioannis V.;
    • Gavriatopoulou, Maria;
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Dialoupi, Ioanna;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Tselegkidi, Maria-Irini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Psimenou, Erasmia;
    • Spyropoulou-Vlachou, Marylin;
    • Gatou, Anastasia;
    • Terpos, Evangelos;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    27

    Next generation flow cytometry for MRD detection in patients with AL amyloidosis.

    Published in:
    Amyloid, 2021, v. 28, n. 1, p. 19, doi. 10.1080/13506129.2020.1802713
    By:
    • Kastritis, Esftathios;
    • Kostopoulos, Ioannis V.;
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Tselegkidi, Maria Irini;
    • Roussou, Maria;
    • Papathoma, Alexandra;
    • Eleutherakis-Papaioakovou, Evangelos;
    • Dialoupi, Ioanna;
    • Kanellias, Nikolaos;
    • Ntalianis, Argyrios;
    • Rousakis, Pantelis;
    • Trougakos, Ioannis P.;
    • Tsitsilonis, Ourania;
    • Gakiopoulou, Charikleia;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    28

    Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis.

    Published in:
    Amyloid, 2021, v. 28, n. 1, p. 3, doi. 10.1080/13506129.2020.1798224
    By:
    • Kastritis, Efstathios;
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Dialoupi, Ioanna;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Karatrasoglou, Eleni A.;
    • Tselegkidi, Maria Irini;
    • Ntalianis, Argyrios;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gakiopoulou, Charikleia;
    • Papanikolaou, Asimina;
    • Papathoma, Alexandra;
    • Spyropoulou-Vlachou, Marylin;
    • Psimenou, Erasmia;
    • Stamatelopoulos, Kimon;
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos
    Publication type:
    Article
    29

    Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis.

    Published in:
    Amyloid, 2018, v. 25, n. 4, p. 234, doi. 10.1080/13506129.2018.1540410
    By:
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Roussou, Maria;
    • Bagratuni, Tina;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Ziogas, Dimitrios C.;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Dialoupi, Ioanna;
    • Ntanasis-Stathopoulos, Ioannis;
    • Spyropoulou-Vlachou, Mairylin;
    • Psimenou, Erasmia;
    • Gakiopoulou, Harikleia;
    • Marinaki, Smaragdi;
    • Papadopoulou, Elektra;
    • Ntalianis, Argyrios;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    30

    Daratumumab May Attenuate Cardiac Dysfunction Related to Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma: A Prospective Study.

    Published in:
    Cancers, 2021, v. 13, n. 20, p. 5057, doi. 10.3390/cancers13205057
    By:
    • Terpos, Evangelos;
    • Stamatelopoulos, Kimon;
    • Makris, Nikolaos;
    • Georgiopoulos, Georgios;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Laina, Ageliki;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Malandrakis, Panagiotis;
    • Delialis, Dimitris;
    • Andreadou, Ioanna;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    31

    Aberrant Plasma Cell Contamination of Peripheral Blood Stem Cell Autografts, Assessed by Next-Generation Flow Cytometry, Is a Negative Predictor for Deep Response Post Autologous Transplantation in Multiple Myeloma; A Prospective Study in 199 Patients.

    Published in:
    Cancers, 2021, v. 13, n. 16, p. 4047, doi. 10.3390/cancers13164047
    By:
    • Kostopoulos, Ioannis V.;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Rousakis, Pantelis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Panteli, Chrysanthi;
    • Orologas-Stavrou, Nikolaos;
    • Kanellias, Nikolaos;
    • Malandrakis, Panagiotis;
    • Liacos, Christine-Ivy;
    • Papaioannou, Nikos E.;
    • Papanota, Aristea-Maria;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Angelis, Nikolaos V.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania E.;
    • Terpos, Evangelos
    Publication type:
    Article
    32

    A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma.

    Published in:
    Cancers, 2021, v. 13, n. 15, p. 3877, doi. 10.3390/cancers13153877
    By:
    • Papanota, Aristea-Maria;
    • Tsiakanikas, Panagiotis;
    • Kontos, Christos K.;
    • Malandrakis, Panagiotis;
    • Liacos, Christine-Ivy;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Avgeris, Margaritis;
    • Dimopoulos, Meletios-Athanasios;
    • Scorilas, Andreas;
    • Terpos, Evangelos
    Publication type:
    Article
    33

    Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study.

    Published in:
    Cancers, 2021, v. 13, n. 6, p. 1257, doi. 10.3390/cancers13061257
    By:
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Katodritou, Eirini;
    • Kyrtsonis, Marie-Christine;
    • Douka, Vassiliki;
    • Spanoudakis, Emmanouil;
    • Papatheodorou, Athanasios;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Gavriatopoulou, Maria;
    • Makras, Polyzois;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A;
    • Atanackovic, Djordje
    Publication type:
    Article
    34

    Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma.

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3245, doi. 10.3390/cancers12113245
    By:
    • Papadimitriou, Konstantinos;
    • Tsakirakis, Nikolaos;
    • Malandrakis, Panagiotis;
    • Vitsos, Panagiotis;
    • Metousis, Andreas;
    • Orologas-Stavrou, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Pothos, Panagiotis;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Terpos, Evangelos;
    • Tsitsilonis, Ourania E.;
    • Kostopoulos, Ioannis V.
    Publication type:
    Article
    35
    36
    37

    Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome.

    Published in:
    2019
    By:
    • Trakada, Georgia;
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Velentza, Lemonia;
    • Fotiou, Despina;
    • Ziogas, Dimitrios C.;
    • Panagiotidis, Ioannis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Roussou, Maria;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kallianos, Anastasios;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    journal article
    38

    Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with multiple myeloma

    Published in:
    2020
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papatheodorou, Athanasios;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Dialoupi, Ioanna;
    • Roussou, Maria;
    • Kokkali, Nikoletta-Aikaterini;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Letter
    39

    Cardiac mechanics in response to proteasome inhibition: a prospective study.

    Published in:
    European Heart Journal - Cardiovascular Imaging, 2023, v. 24, n. 5, p. 643, doi. 10.1093/ehjci/jeac168
    By:
    • Makris, Nikolaos;
    • Georgiopoulos, Georgios;
    • Laina, Aggeliki;
    • Tselegkidi, Maria-Eirini;
    • Fotiou, Despoina;
    • Kanellias, Nikolaos;
    • Eleftherakis-Papaiakovou, Evaggelos;
    • Migkou, Magda;
    • Papanagnou, Eleni-Dimitra;
    • Katogiannis, Konstantinos;
    • Petropoulos, Ioannis;
    • Anninos, Hector;
    • Bampatsias, Dimitrios;
    • Maneta, Eleni;
    • Samouilidou, Elisabeth;
    • Nikas, Dimitris;
    • Ciliberti, Giorgia;
    • Stellos, Konstantinos;
    • Terpos, Evaggelos;
    • Gavriatopoulou, Maria
    Publication type:
    Article
    40

    Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice.

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 7, p. 2224, doi. 10.3390/jcm14072224
    By:
    • Ntanasis-Stathopoulos, Ioannis;
    • Koutoulidis, Vassilis;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Spiliopoulou, Vasiliki;
    • Filippatos, Charalampos;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Theodorakakou, Foteini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • Moulopoulos, Lia-Angela;
    • Gavriatopoulou, Maria
    Publication type:
    Article
    41

    Trabecular Bone Score as a Complementary Tool for the Assessment of Bone Mineral Density in Patients with Asymptomatic Monoclonal Gammopathies.

    Published in:
    Journal of Clinical Medicine, 2024, v. 13, n. 21, p. 6461, doi. 10.3390/jcm13216461
    By:
    • Drakoulidou, Styliani;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kyritsi, Aikaterini;
    • Koutoulidis, Vassilis;
    • Malandrakis, Panagiotis;
    • Kanellias, Nikolaos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Gavriatopoulou, Maria;
    • Chalazonitis, Athanasios;
    • Terpos, Evangelos
    Publication type:
    Article
    42

    Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 12, p. 3355, doi. 10.3390/jcm11123355
    By:
    • Gavriilaki, Eleni;
    • Dalampira, Dimitra;
    • Theodorakakou, Foteini;
    • Liacos, Christine-Ivy;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Verrou, Evgenia;
    • Triantafyllou, Theodora;
    • Sevastoudi, Aggeliki;
    • Koravou, Evaggelia-Evdoxia;
    • Touloumenidou, Tasoula;
    • Varelas, Christos;
    • Papalexandri, Apostolia;
    • Sakellari, Ioanna;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios;
    • Katodritou, Eirini
    Publication type:
    Article
    43

    Newly Diagnosed Multiple Myeloma Patients with Skeletal-Related Events and Abnormal MRI Pattern Have Poor Survival Outcomes: A Prospective Study on 370 Patients.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 11, p. 3088, doi. 10.3390/jcm11113088
    By:
    • Kanellias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Koutoulidis, Vassilis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Malandrakis, Panagiotis;
    • Bagratuni, Tina;
    • Mavropoulos-Papoudas, Stylianos;
    • Roussou, Maria;
    • Kastritis, Efstathios;
    • Moulopoulos, Lia A.;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    44

    Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction.

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 10, p. 3201, doi. 10.3390/jcm9103201
    By:
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Papassotiriou, Gerasimos-Petros;
    • Kastritis, Efstathios;
    • Margeli, Alexandra;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Roussou, Maria;
    • Gavriatopoulou, Maria;
    • Malandrakis, Panagiotis;
    • Psimenou, Erasmia;
    • Papassotiriou, Ioannis;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    45

    Prognostic impact of translocation t(11;14) and of other cytogenetic abnormalities in patients with AL amyloidosis in the era of contemporary therapies.

    Published in:
    European Journal of Haematology, 2023, v. 111, n. 2, p. 271, doi. 10.1111/ejh.13993
    By:
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Malandrakis, Panagiotis;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Eleutherakis Papaiakovou, Evangelos;
    • Terpos, Evangelos;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Dimopoulos, Meletios Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Article
    46

    Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00988-x
    By:
    • Kostopoulos, Ioannis V.;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Rousakis, Pantelis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Panteli, Chrysanthi;
    • Malandrakis, Panagiotis;
    • Migkou, Magdalini;
    • Angelis, Nikolaos;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Theodorakakou, Foteini;
    • Krevvata, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania;
    • Kastritis, Efstathios
    Publication type:
    Article
    47

    The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 8, p. 1, doi. 10.1038/s41408-021-00530-3
    By:
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Papanagnou, Eleni-Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis P.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    48

    Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00381-4
    By:
    • Fotiou, Despina;
    • Roussou, Maria;
    • Gakiopoulou, Charikleia;
    • Psimenou, Erasmia;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Dialoupi, Ioanna;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Giannouli, Stavroula;
    • Delavinia, Christina;
    • Efstathiou, Kostantinos;
    • Kontogiannis, Sofoklis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    49

    The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 9, p. N.PAG, doi. 10.1038/s41408-020-00360-9
    By:
    • Gavriatopoulou, Maria;
    • Βoultadaki, Andriani;
    • Koutoulidis, Vassilis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Bourgioti, Charis;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Moulopoulos, Lia-Angela
    Publication type:
    Article
    50

    Toll-Like Receptor 4 Activation Promotes Multiple Myeloma Cell Growth and Survival Via Suppression of The Endoplasmic Reticulum Stress Factor Chop.

    Published in:
    Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39672-7
    By:
    • Bagratuni, Tina;
    • Sklirou, Aimilia D.;
    • Kastritis, Efstathios;
    • Liacos, Christine Ivy;
    • Spilioti, Christina;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Trougakos, Ioannis P.;
    • Dimopoulos, Meletios A.
    Publication type:
    Article